FDA Decisions and Biotech Stocks: How PDUFA Dates Work

Why FDA Decisions Matter to Biotech Stocks

For a biotech company whose value rests on one or two drug candidates, an FDA decision can change the whole picture of the business in a single day. The agency either approves the application or it does not, so the uncertainty around the date is large and it resolves at once. That is why FDA decisions are among the events with the widest range of price reactions in equities. We do not publish typical move sizes, because we have not measured them on a sample we would defend.

What Is a PDUFA Date?

PDUFA stands for Prescription Drug User Fee Act. Under it, drug sponsors pay user fees and the FDA commits to review goals. When the FDA files a New Drug Application (NDA) or a Biologics License Application (BLA), the application gets a goal date, usually called the PDUFA date: the date by which the agency aims to finish its review and act.

Under the current PDUFA goals, a standard review targets 10 months and a priority review 6 months. For new molecular entities the clock starts after the FDA's 60-day filing period, so the goal date lands about 12 or 8 months after submission. A major amendment to the application during review can extend the goal date by 3 months.

The FDA does not publish PDUFA dates itself. Companies usually disclose them in press releases or SEC filings once the application is accepted. That makes a PDUFA date a known date with an unknown outcome, which is unusual among market events.

How FDA Decisions Are Announced

Approval. The drug can be marketed in the US for the approved use. The approval letter and the label define what the company may claim.

Complete Response Letter (CRL). The application cannot be approved in its current form. The letter lists what has to be fixed before resubmission. Companies often summarise the letter in a press release; the summary is the company's reading, not the letter itself.

Advisory committee (AdCom) votes. Before some decisions the FDA convenes an independent panel. The vote is not binding: the FDA has approved drugs a panel voted against, and the reverse.

Timing. The FDA can act before the goal date, on it, or miss it. Companies often disclose a decision outside regular market hours, so the first trades on the news can happen in extended hours.

Public Data Around a Biotech Ticker

Several public datasets describe the positioning around a biotech name. None of them tells you the outcome or the direction of the reaction.

Short interest. FINRA publishes consolidated short interest twice a month, about two weeks after each settlement date. Example: as of FINRA settlement 2026-09-30, SRPT had 22.8M shares sold short and 8.6 days to cover, 10.4% less than at the 2026-09-15 settlement (source: FINRA, via the SRPT short interest and fails-to-deliver page). On the same settlement date MRNA had 30.9M shares sold short and 1.8 days to cover (source: FINRA, via the MRNA short interest, Form 4 and analyst page).

Fails-to-deliver. The SEC publishes fails-to-deliver files twice a month, with about six weeks of delay. A fail is a settlement record, not a bet on the outcome.

Implied volatility. Option prices usually carry higher implied volatility ahead of a known decision date. TradeAI News does not show options data for single biotech stocks.

The Short Interest & FTD tracker shows these figures market-wide, and the VRTX page and NVAX page show the same sections for two more biotech names. The ticker pages do not show FDA decisions or PDUFA dates.

FDA Events in TradeAI News

TradeAI News polls the FDA feeds in its source roster, press release wires and SEC EDGAR. On 2026-10-17 the roster on the features page, listed these FDA feeds among those that had delivered items in the previous week: FDA — CDER, FDA — MedWatch and FDA — Press Announcements. When an FDA item is picked up, it is labelled as an event and appears in the dashboard event feed with its type. Events are detected a median of 23.8 minutes after the source publishes them (90th percentile: 50.9 minutes), measured over the 30 days to Oct 2, 2026.

The dashboard Financial Calendar covers macro releases only (Federal Reserve meetings, CPI, jobs, GDP). It does not list PDUFA dates or advisory committee meetings. For the event types and what shapes a reaction, see market events explained.